Patient monitoring and respiratory care devices provider Covidien's Nellcor Pulse Oximeters has obtained 510(k) clearance with labeling from US Food and Drug Administration (FDA). Nellcor Pulse Oximeters facilitates in noninvasive ...
Tags: Covidien's Nellcor, Medicine
Covidien has announced that its Nellcor pulse oximetry portfolio received the US Food and Drug Administration (FDA) 510(k) clearance for motion claims. The Nellcor pulse oximetry portfolio, which is used to measure arterial oxygen ...
Tags: Covidien, Motion Claims
Covidien will introduce its Nellcor Bedside SpO2 Patient Monitoring system at the European Society of Anesthesiology Congress held between 9-12 June 2012 in Paris, France. The Nellcor system utilizes OxiMax technology for monitoring ...
Tags: European Society of Anesthesiology Congress, Patient Monitoring system
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Covidien's Nellcor bedside SpO2 patient monitoring system. The Nellcor bedside SpO2 monitor, which utilizes OxiMax technology, is designed for detecting heart rate ...
Tags: FDA, clearance, Nellcor, SpO2 patient monitoring system, SpO2 monitor